Coronavirus Response – Active Support for Hospitalised COVID-19 patients
** Recruitment not started due to lack of funding **
The CRASH-19 trial will assess the effectiveness and safety of supportive care interventions for patients hospitalised with suspected or confirmed acute COVID-19 infection with a focus on cardiac and pulmonary protection. We will evaluate the effects of aspirin, the angiotensin receptor blocker losartan, and simvastatin compared with standard care.
The COVID-19 Clinical Research Coalition brings together individuals and institutions working to fast-track research that will provide evidence on COVID-19 prevention, diagnosis, and case management in resource-limited settings. This is the …
We are excited to announce that the first approvals for the CRASH-19 trial have been received! Next up are ethics are regulatory approvals for Nigeria and Pakistan…